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Disparities in access to healthcare and ultimately in 
outcomes continue to be reported on ethnic grounds 
from around the globe.1 Although such inequalities have 
existed for many decades,2 the mortality and morbidity 
data from the Covid-19 pandemic has brought these is-
sues to the fore.3-6 The increased predisposition to some 
rheumatological diseases7 and the continuing increased 
incidence of added 
comorbidity, such as 
coronary heart disease 
in South Asians, poses 
significant healthcare 
challenges,8 as does 
the need to begin 
addressing cultural 
differences in beliefs 
and behaviour at the 
very early stage.9 This 
is an area in which patient organisations such as the 
National Rheumatoid Arthritis Society (NRAS) can play 
a significant role and add great value to patient care.10 
The continued observation of poor disease outcomes in 
South Asians suggests that in spite of the recognition of 
this need, there is still much to be done.11-13 If we are to 
achieve true equality of access to best rheumatological 
care for all, the rheumatology community needs to act 
by proactively addressing the barriers to care and treat-
ment which many ethnic groups currently experience.14 
COVID has shone a light on the inequity of access to 
healthcare generally faced by many ethnic communities 
and we need to grasp all opportunities to improve this 
imbalance.4,6,15,16
APNI JUNG (OUR FIGHT) AGAINST RA
Apni Jung (our fight) against rheumatoid arthritis (RA) 
(www.nras.org.uk/apnijung) was launched by NRAS in 
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ABSTRACT
Covid-19 has affected many populations in the UK, and ethnic minority communities in particular. 
People from ethnic minority communities living with long-term chronic diseases have shown to be 
less engaging with self-management and report having poor medication adherence. The main reason 
to this problem is the way information is delivered to non-English speaking patients. This editorial 
discusses an innovation to over this barriers in rheumatology practice.
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collaboration with Dr. Kanta Kumar in 2016 at the BSR 
Annual Congress, based on the research over many 
years, demonstrating the barriers that people from ethnic 
communities face.9,17-23 They face challenges in accessing 
best care and treatment, and have culturally held health 
beliefs which may be different to the views of non-South 
Asians.17 It is widely recognised that provision of access 
to supported self-management, education, and appropri-
ate information to help people manage their conditions is 
vital in a chronic, fluctuating, and evolving disease, such 
as RA.10 Accessible information and education can help 
people to cope day-to-day with the disease and improve 
their quality of life, through improving self-efficacy.10 
Providing such information and educational resources 
in an accessible format which addresses issues around 
health literacy, facilitates self-management skills which 
can contribute to increased adherence to medication re-
duction in pain and fatigue, improved function, and also 
reduced utilisation of healthcare resources, is extremely 
important.24,25 Access to evidence-based information 
underpins these processes.26 Research has shown that 
people do not just need information about a disease, but 
also want to hear about real-life experiences of others 
with the same disease, as well as have access to peer 
support networks outside the healthcare setting.25 This 
influences how people make choices about treatments, 
how decisions are personalised, and, more importantly, 
how these are understood.9 The Internet is the obvious 
‘go-to’ resource for anyone with a long-term condition, 
such as RA. It can provide information generically and 
quickly. However, without knowing which information 
is from reliable evidence-based sources, patients can 
easily be misinformed or find the information frightening. 
This is especially the case for minority ethnic popula-
tions, in whom information on rheumatology practice 
and care may not be presented in a culturally sensitive 
way, or necessarily in languages that are accessible to 
different ethnic populations.12 To address some of these 
challenges, we launched the NRAS Apni Jung web area 
on the NRAS website. Although people living in South 
Asian countries share genetic and cultural risk factors 
with South Asians living abroad, South Asians residing 
in the UK can differ in socioeconomic status, education, 
healthcare behaviours, attitudes, and illness perceptions 
which can affect their disease management and treat-
ment outcomes.2 In rheumatology practice, departments 
in general produce written resources mainly in English.24 
However, this is inaccessible to those who cannot 
read or write in English, or even in some instances, in 
their mother tongue.12 We know that literacy amongst 
a patient cohort in certain areas of the UK is a barrier 
to understanding written resource material given out in 
rheumatology clinics, even in those who speak English as 
a first language.27 Latif et al.27 found statistically significant 
improvement in knowledge of coronary artery disease, 
after a group of Bangladeshi women viewed a video on 
the topic. Videos would therefore be a better way by 
which to convey key health-related messaging in some 
patient populations. Up until 2016, there were limited 
resources for South Asian patients to access information 
in their own language and in a culturally meaningful way. 
The Apni Jung project aims to educate, empower, and 
engage ethnic minority populations. The initial success 
of the Apni Jung project has been highly encouraging, 
where clinicians have been signposting their patients. 
However, more needs to be done to implement this proj-
ect in the heart of the South Asian communities and in 
routine clinical practice where there are patients of South 
Asian origin.  
This effort requires a multidisciplinary approach, and a 
collective will to improve healthcare and outcomes in 
minority populations. The founders of Apni Jung have 
taken the next step of bringing together senior clinicians 
from a variety of specialties, and most importantly, pa-
tient advocates to form the “Apni Jung Advisory Board” 
to endorse and promote Apni Jung. We believe that 
strengthening the interface with primary care, pharmacy 
practice, and community and rheumatology healthcare 
professionals, will enable us to embed Apni Jung more 
successfully in the care pathways of rheumatology pa-
tients. The Apni Jung Board are aware that many people 
from ethnic communities do not always see patient 
organisations as having an important role to play in their 
care pathway. As a result, many do not seek information 
or support from patient organisations and rely solely 
on their doctor’s advice. To achieve a multidimensional 
approach to embed Apni Jung in the care pathway, the 
Advisory Board has pledged to raise awareness of this 
project much more widely across healthcare settings. 
This editorial highlights the important point that the 
way in which the rheumatology community currently 
provides information to patients of South Asian origin is 
not enabling and empowering them to self-manage their 
long-term conditions effectively. Sadly, poor knowledge 
and understanding of rheumatology diseases, appears 
to be very common amongst these populations, and 
Apni Jung is a freely available resource which health pro-
fessionals should sign-post their patients to. In addition 
to conveying effective, evidence-based advice about 
disease recognition and management, we must include 
the vital information that Apni Jung can play a key role in 
empowering patients. 
CONCLUSION
We would like to encourage all rheumatology health 
professionals and primary and community care profes-
sionals involved in the care of South Asian populations 
to ensure that they sign-post patients to this important 
resource at point of diagnosis and indeed at any point 
in the patient’s journey. The rheumatology community 
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serving ethnic minority population across the global can 
access this website for their patients: www.nras.org.uk/
apnijung 
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